Related references
Note: Only part of the references are listed.Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function
Marcel Roos et al.
CLINICAL ENDOCRINOLOGY (2008)
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men
Richard Marsell et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors
T. Hansen et al.
EUROPEAN RADIOLOGY (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice
Jason R. Stubbs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The prevalence and quantification of atherosclerosis in an elderly population assessed by whole-body magnetic resonance angiography
T. Hansen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L
M. Flodin et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2007)
Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
M. Inaba et al.
OSTEOPOROSIS INTERNATIONAL (2006)
The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: Frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23
KE White et al.
ENDOCRINE REVIEWS (2006)
Whole-body magnetic resonance angiography of patients using a standard clinical scanner
T Hansen et al.
EUROPEAN RADIOLOGY (2006)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study
L Lind et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Role of fibroblast growth factor 23 in health and in chronic kidney disease
M Fukagawa et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2005)
Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
S Nakanishi et al.
KIDNEY INTERNATIONAL (2005)
FGF-23 in patients with end-stage renal disease on hemodialysis
Y Imanishi et al.
KIDNEY INTERNATIONAL (2004)
Vascular calcification in chronic kidney disease
WG Goodman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
T Shimada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Pathophysiology of vascular calcification in chronic kidney disease
SM Moe et al.
CIRCULATION RESEARCH (2004)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
T Shigematsu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Whole body MR angiography screening
SG Ruehm et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease
CU Herborn et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Serum FGF23 levels in normal and disordered phosphorus homeostasis
TJ Weber et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Whole-body three-dimensional MR angiography with a rolling table platform:: Initial clinical experience
M Goyen et al.
RADIOLOGY (2002)
Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
P Raggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Prognostic significance of endothelial dysfunction in hypertensive patients
F Perticone et al.
CIRCULATION (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Share Paper
